Skip to main content

Table 1 The correlation between the expression of serum miR-454 and the clinicopathological characteristics of ovarian cancer patients

From: miR-454 suppresses the proliferation and invasion of ovarian cancer by targeting E2F6

Characteristics

n

miR-454 expression

P-value

Age

   

 < 59

7

6.41 ± 5.33

0.69

 ≥ 59

6

8.37 ± 11.39

 

Clinical stage

   

 I–II

7

12.13 ± 8.92

0.016*

 III–IV

6

1.70 ± 0.77

 

Lymph node metastasis

   

 Yes

7

5.69 ± 10.59

0.47

 No

6

9.21 ± 4.88

 
  1. *P < 0.05